National Multiple Sclerosis Society
Recurring EventCMEs expire on August 31, 2014.
This publication is targeted to neurologists who have an interest in treating multiple sclerosis (MS). Upon completion of this educational activity, the participant should be able to: 1) Assess current outcomes data for the latest MRI techniques and newer imaging technologies in MS; 2) Describe applicability of newer imaging technologies to clinical practice in MS; 3) Describe results of MRI and other imaging outcomes from research involving new and emerging MS disease-modifying agents and 4) Discuss research about the clinical correlations of brain atrophy with MS symptoms and disease progression. This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Consortium of Multiple Sclerosis Centers (CMSC) and the Delaware Media Group. The CMSC is accredited by the ACCME to provide continuing medical education for physicians.
The CMSC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.